Demographics, treatment patterns and clinical outcomes in ROS1-positive non-small cell lung cancer: A referral tertiary cancer centre experience from a low-middle income country

被引:0
|
作者
Panda, G. S. [1 ]
Noronha, V. [1 ]
Patil, V. M. [1 ]
Joshi, A. P. [1 ]
Menon, N. S. [1 ]
Singh, A. C. [1 ]
Kumar, R. [2 ]
Pai, T. [2 ]
Shetty, O. [2 ]
Janu, A. [3 ]
Chakrabarty, N. [3 ]
Purandare, N. [4 ]
Dey, S. [1 ]
Prabhash, K. [1 ]
机构
[1] Tata Mem Hosp, Tata Mem Ctr, Med Oncol, Mumbai, Maharashtra, India
[2] Tata Mem Hosp, Tata Mem Ctr, Pathol, Mumbai, Maharashtra, India
[3] Tata Mem Hosp, Tata Mem Ctr, Radiol, Mumbai, Maharashtra, India
[4] Tata Mem Hosp, Tata Mem Ctr, Bioimaging, Mumbai, Maharashtra, India
关键词
D O I
10.1016/j.annonc.2022.10.428
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
391P
引用
收藏
页码:S1594 / S1595
页数:2
相关论文
共 50 条
  • [31] Phase II study of brigatinib in ROS1-positive non-small cell lung cancer patients previously treated with crizotinib
    Goto, Yasushi
    Niho, Seiji
    Daga, Haruko
    Sakakibara-Konishi, Sakakibara-Konishi
    Tanaka, Hiroshi
    Ohashi, Kadoaki
    Toyozawa, Ryo
    Kotani, Masahiro
    Takahashi, Toshiaki
    Hattori, Yoshihiro
    Morise, Masahiro
    Ikeda, Takaya
    Matsumoto, Shingo
    Yoh, Kiyotaka
    Nomura, Shogo
    Goto, Koichi
    ANNALS OF ONCOLOGY, 2022, 33 : S475 - S475
  • [32] Real-world studies of crizotinib in patients with ROS1-positive non-small-cell lung cancer: experience from China
    Zhong, Hua
    Lu, Jun
    Wang, Mengzhao
    Han, Baohui
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2025, 14 (02)
  • [33] KRAS Mutation Subtypes in Non-Small Cell Lung Cancer and Clinical Outcomes: A Single Centre Experience
    Davis, A.
    Lee, J.
    Boyer, M.
    Pavlakis, N.
    Cooper, W.
    Yu, B.
    Heller, G.
    Kao, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1152 - S1152
  • [34] Lorlatinib in pretreated ALK/ROS1-positive non-small cell lung cancer (NSCLC): Results from the German early access program
    Frost, N.
    Christopoulos, P.
    Kauffmann-Guerrero, D.
    Stratmann, J. A.
    Riedel, R.
    Schaefer, M.
    Alt, J.
    Guetz, S.
    Brinkmann, J.
    Griesinger, F.
    ANNALS OF ONCOLOGY, 2020, 31 : S874 - S874
  • [35] Treatment outcomes in patients with extensive stage small cell lung cancer - Experience from a tertiary Indian cancer centre
    Bharath, R.
    Menon, H.
    Ghadyalpatil, N. S.
    Prabhash, K.
    Hingmire, S. S.
    Karanth, N.
    Jain, K.
    Gaikwad, K.
    Agarwal, J. P.
    Parikh, P. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] Should Crizotinib Take It All in ROS1-Positive Non-Small-Cell Lung Cancer? Reply
    Wu, Yi-Long
    Goto, Koichi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (31) : 3177 - +
  • [37] Efficacy of lorlatinib in patients (pts) with ROS1-positive advanced non-small cell lung cancer (NSCLC) and ROS1 kinase domain mutations
    Solomon, B. J.
    Martini, J-F.
    Ou, S-H. I.
    Chiari, R.
    Soo, R. A.
    Bearz, A.
    Li, S.
    Thurm, H.
    Lin, C-C.
    Riely, G. J.
    Bauer, T. M.
    Shaw, A. T.
    ANNALS OF ONCOLOGY, 2018, 29 : 495 - 495
  • [38] Focus on ROS1-Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, Resistance Mechanisms and the Newer Generation of Targeted Therapies
    D'Angelo, Alberto
    Sobhani, Navid
    Chapman, Robert
    Bagby, Stefan
    Bortoletti, Carlotta
    Traversini, Mirko
    Ferrari, Katia
    Voltolini, Luca
    Darlow, Jacob
    Roviello, Giandomenico
    CANCERS, 2020, 12 (11) : 1 - 18
  • [39] Crizotinib inhibition of ROS1-positive tumours in advanced non-small-cell lung cancer: a Canadian perspective
    Bebb, D. G.
    Agulnik, J.
    Albadine, R.
    Banerji, S.
    Bigras, G.
    Butts, C.
    Couture, C.
    Cutz, J. C.
    Desmeules, P.
    Ionescu, D. N.
    Leigh, N. B.
    Melosky, B.
    Morzycki, W.
    Rashid-Kolvear, F.
    Sekhon, H. S.
    Smith, A. C.
    Stockley, T. L.
    Torlakovic, E.
    Xu, Z.
    Tsao, M. S.
    CURRENT ONCOLOGY, 2019, 26 (04) : E551 - E557
  • [40] Palliative Surgery for Advanced Cancer: Clinical Profile, Spectrum of Surgery and Outcomes from a Tertiary Care Cancer Centre in Low-Middle-Income Country
    Deo, S. V. S.
    Kumar, Naveen
    Rajendra, Vinaya Kumar J.
    Kumar, Sunil
    Bhoriwal, Sandeep Kumar
    Ray, Mukurdipi
    Bhatnagar, Sushma
    Mishra, Seema
    INDIAN JOURNAL OF PALLIATIVE CARE, 2021, 27 (02) : 281 - 285